HeraMED (ASX:HMD) Pre-Tax Income : A$-5.49 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. HeraMED's pretax income for the six months ended in Dec. 2024 was A$-2.28 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was A$-5.49 Mil. HeraMED's pretax margin was -1,244.81%.

During the past 7 years, HeraMED's highest Pretax Margin was -1118.27%. The lowest was -8566.67%. And the median was -2229.81%.

HeraMED Pre-Tax Income Historical Data

The historical data trend for HeraMED's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Pre-Tax Income Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Pre-Tax Income

Get a 7-Day Free Trial

-4.37

-7.88

-7.17

-6.61

-5.49

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial								-2.59	-3.31	-3.30	-3.21	-2.28

Competitive Comparison of HeraMED's Pre-Tax Income

For the Medical Devices subindustry, HeraMED's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where HeraMED's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

HeraMED Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

HeraMED's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-5.568	+	0.117	+	-0.048	+	0.009	+	-0.0010000000000003
	=	-5.49

HeraMED's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.225	+	-0.068	+	0.01	+	0.005	+	4.4408920985006E-16
	=	-2.28

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-5.49 Mil.

HeraMED (ASX:HMD) Pre-Tax Income Explanation

HeraMED's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.278	/	0.183
	=	-1,244.81%

During the past 7 years, HeraMED's highest Pretax Margin was -1118.27%. The lowest was -8566.67%. And the median was -2229.81%.

HeraMED Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of HeraMED's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

HeraMED Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines